2m 2m 2m 2m 2m 2m 2m
VIVOS THERAP (VVOS)
NASDAQ
$0.45-$0.02 (-3.92%)
Price as of Jun 23, 2026 7:59 PM EDT- $5.6MMarket Cap
- -86.32%1-Year Change
- Medical DevicesIndustry
VIVOS THERAP (VVOS)
$0.45-$0.02 (-3.92%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 6.5M -17.61% | 7.9M -42.95% | 13.8M -13.87% | 16.0M -5.10% | |
Cost of Revenue | 6.9M +14.79% | 6.0M +8.72% | 5.5M -7.91% | 6.0M +40.27% | |
Gross Profit | 10.5M +16.89% | 9.0M +9.04% | 8.3M -17.45% | 10.0M -20.51% | |
Sales and Marketing Expense | 1.4M -19.12% | 1.7M -29.83% | 2.5M -53.80% | 5.3M -3.80% | |
Research and Development Expense | -100,000 0.00% | -100,000 0.00% | -100,000 -50.00% | -200,000 N/A | |
Depreciation and Amortization Expense | 1.3M +125.30% | 581,000 -6.44% | 621,000 -7.17% | 669,000 -8.73% | |
Total Operating Expenses | 30.4M +50.75% | 20.2M -21.03% | 25.6M -27.06% | 35.0M +6.26% | |
Operating Profit | -19.9M +78.09% | -11.2M -35.41% | -17.3M -30.90% | -25.0M +22.81% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -1.4M N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | -1.4M N/A | 0 N/A | 0 N/A | 0 -100.00% | |
Total Nonoperating Income and Expense | -1.5M +1,246.36% | -110,000 -48.11% | -212,000 +11.58% | -190,000 +2,011.11% | |
Income before Taxes | -21.2M +90.64% | -11.1M -18.02% | -13.6M -43.04% | -23.8M +17.53% | |
Income Taxes | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -21.2M +90.10% | -11.1M -18.02% | -13.6M -43.04% | -23.8M +17.53% | |
Net Income from Continuing Operations Applicable to Common | -21.2M +90.64% | -11.1M -18.02% | -13.6M -43.04% | -23.8M +17.53% | |
Basic EPS and Net Income | -2.07 -6.76% | -2.22 -80.07% | -11.14 +971.15% | -1.04 +8.33% | |
Diluted EPS and Net Income | -2.07 -6.76% | -2.22 -80.07% | -11.14 +971.15% | -1.04 +8.33% | |
Basic Weighted Average Shares | 10.3M +104.66% | 5.0M +311.67% | 1.2M -99.99% | 23.0B +108,279.03% | |
Diluted Weighted Average Shares | 10.3M +104.66% | 5.0M +311.67% | 1.2M -99.99% | 23.0B +108,279.03% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 2.0M -67.59% | 6.3M +281.01% | 1.6M -53.31% | 3.5M -85.36% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 2.0M -67.59% | 6.3M +281.01% | 1.6M -53.31% | 3.5M -85.36% | |
Total Current Assets | 4.4M -41.34% | 7.5M +203.66% | 2.5M -54.63% | 5.4M -80.15% | |
Accumulated Depreciation | 2.9M +2.73% | 2.9M +22.87% | 2.3M +32.69% | 1.8M +41.03% | |
Property and Plant and Equipment and Net | 3.8M +12.15% | 3.4M +1.09% | 3.3M +7.53% | 3.1M +9.10% | |
Total Long-Term Assets | 3.8M +12.15% | 3.4M +1.09% | 3.3M +7.53% | 3.1M +9.10% | |
Total Assets | 25.2M +64.56% | 15.3M +42.44% | 10.7M -21.79% | 13.7M -59.27% | |
Income Taxes Payable | 799,000 +66.11% | 481,000 N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 8.4M N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 18.1M +263.12% | 5.0M -31.71% | 7.3M +6.99% | 6.8M -9.27% | |
Total Long-Term Debt | 469,000 -60.92% | 1.2M 0.00% | 1.2M N/A | N/A N/A | |
Total Long-Term Liabilities | 1.3M +14.84% | 1.1M -37.46% | 1.8M -14.06% | 2.1M +228.55% | |
Total Liabilities | 26.7M +264.28% | 7.3M -28.97% | 10.3M +15.70% | 8.9M +9.44% | |
Retained Earnings | -125.4M +20.32% | -104.2M +11.97% | -93.1M +17.09% | -79.5M +42.87% | |
Total Stockholders Equity | -1.5M N/A | N/A N/A | 411,000 -91.44% | 4.8M -81.20% | |
Total Shares Outstanding | 9.3M +57.68% | 5.9M +221.15% | 1.8M -92.03% | 23.0M 0.00% | |
Cash Flow | |||||
Cash from Operating Activities | -15.3M +20.27% | -12.7M +6.24% | -11.9M -39.01% | -19.6M +24.48% | |
Capital Expenditures | 2.3M +312.15% | 568,000 -29.27% | 803,000 -13.10% | 924,000 -61.44% | |
Cash from Investing Activities | -7.5M +1,225.00% | -568,000 -33.41% | -853,000 -7.68% | -924,000 -64.57% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 18.6M +3.82% | 17.9M +63.65% | 10.9M N/A | N/A N/A | |
Financials Ratio | |||||
Gross Margin | -6.38% -126.99% | 23.65% -60.54% | 59.93% -4.15% | 62.53% -16.24% | |
Operating Margin | -306.67% +116.16% | -141.87% +13.20% | -125.32% -19.77% | -156.21% +29.41% | |
Return on Assets | -104.71% +22.30% | -85.62% -22.94% | -111.11% +10.45% | -100.59% +46.31% | |
Return on Equity | N/A N/A | N/A N/A | -521.22% +231.60% | -157.19% +64.47% | |
Revenue Growth | -17.61% -58.98% | -42.95% +209.57% | -13.87% +172.06% | -5.10% -117.45% | |
Current Ratio | 0.24 -83.85% | 1.50 +344.67% | 0.34 -57.59% | 0.80 -78.12% | |
Cash Ratio | 0.11 -91.08% | 1.26 +457.90% | 0.23 -56.36% | 0.52 -83.86% | |
Debt-to-Equity Ratio | -5.92 N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | 0.35 N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow